Trials / Terminated
TerminatedNCT04026334
Evaluation of V.A.C. VERAFLO CLEANSE CHOICE™ Dressing Using Normal Saline to Promote Increased Healthy Wound Bed Tissue
Evaluation of Hydromechanical Cleansing Using Normal Saline With V.A.C. VERAFLO CLEANSE CHOICE™ Dressing and NPWT-d to Promote Increased Healthy Wound Bed Tissue
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- 3M · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The study goal is to evaluate the ability of the V.A.C. ULTA™ Negative Pressure Wound Therapy System and V.A.C. VERAFLO CLEANSE CHOICE ™ (VFCC) dressing system with saline as an irrigant in increasing viable tissue in full thickness wounds (such as chronic, acute, traumatic, sub-acute, and dehisced wounds and/or ulcers) with difficult to manage bioburden and slough.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | V.A.C. VERAFLO CLEANSE CHOICE™ dressing with Normal Saline | -125mmHg, 10 minute soak time, 3.5 hours of negative pressure therapy |
Timeline
- Start date
- 2019-07-25
- Primary completion
- 2020-08-28
- Completion
- 2020-08-28
- First posted
- 2019-07-19
- Last updated
- 2022-08-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04026334. Inclusion in this directory is not an endorsement.